MXPA05008126A - Inhibidores de girasa y uso de los mismos. - Google Patents
Inhibidores de girasa y uso de los mismos.Info
- Publication number
- MXPA05008126A MXPA05008126A MXPA05008126A MXPA05008126A MXPA05008126A MX PA05008126 A MXPA05008126 A MX PA05008126A MX PA05008126 A MXPA05008126 A MX PA05008126A MX PA05008126 A MXPA05008126 A MX PA05008126A MX PA05008126 A MXPA05008126 A MX PA05008126A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- gyrase inhibitors
- relates
- present
- gyrase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Abstract
La presente invencion se relaciona con compuestos que inhiben la girasa bacteriana y/o la Topo IV y con las composiciones farmaceuticamente aceptables que comprenden los compuestos. Estos compuestos, y las composiciones de los mismos, son utiles para tratar infecciones bacterianas. Por consiguiente, la presente invencion tambien se relaciona con los metodos para tratar infecciones bacterianas en mamiferos. Formula (I). (ver formula (I)).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44391703P | 2003-01-31 | 2003-01-31 | |
PCT/US2004/002541 WO2005012292A1 (en) | 2003-01-31 | 2004-01-29 | Gyrase inhibitors and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05008126A true MXPA05008126A (es) | 2006-03-30 |
Family
ID=34115255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05008126A MXPA05008126A (es) | 2003-01-31 | 2004-01-29 | Inhibidores de girasa y uso de los mismos. |
Country Status (25)
Country | Link |
---|---|
US (3) | US7495014B2 (es) |
EP (1) | EP1592686B1 (es) |
JP (2) | JP4691033B2 (es) |
KR (1) | KR20060056270A (es) |
CN (1) | CN100393714C (es) |
AR (1) | AR042956A1 (es) |
AT (1) | ATE435859T1 (es) |
AU (1) | AU2004261545B2 (es) |
CA (1) | CA2513463C (es) |
CY (1) | CY1109385T1 (es) |
DE (1) | DE602004021904D1 (es) |
DK (1) | DK1592686T3 (es) |
ES (1) | ES2327642T3 (es) |
HK (1) | HK1087699A1 (es) |
IL (1) | IL169720A (es) |
MX (1) | MXPA05008126A (es) |
MY (1) | MY139124A (es) |
NO (1) | NO20053845L (es) |
NZ (1) | NZ541885A (es) |
PT (1) | PT1592686E (es) |
RU (1) | RU2350612C2 (es) |
SI (1) | SI1592686T1 (es) |
TW (1) | TWI334416B (es) |
WO (1) | WO2005012292A1 (es) |
ZA (1) | ZA200505773B (es) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003105846A1 (en) * | 2002-06-13 | 2003-12-24 | Vertex Pharmaceuticals Incorporated | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
US8193352B2 (en) | 2003-01-31 | 2012-06-05 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US8404852B2 (en) | 2003-01-31 | 2013-03-26 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US7569591B2 (en) * | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US7582641B2 (en) | 2003-01-31 | 2009-09-01 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
US7618974B2 (en) | 2003-01-31 | 2009-11-17 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
WO2006025978A2 (en) * | 2004-07-23 | 2006-03-09 | University Of Medicine And Dentistry Of New Jersey | Non-antibiotic intervention of chlamydial infection |
RS53599B1 (en) | 2005-05-10 | 2015-02-27 | Intermune, Inc. | PIRIDON DERIVATIVES FOR STRESS MODULATION OF ACTIVATED PROTEIN KINASE SYSTEMS |
DE102005028862A1 (de) * | 2005-06-22 | 2007-01-11 | Sanofi-Aventis Deutschland Gmbh | Substituierte Heterocyclen, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
EP1948635A1 (en) * | 2005-11-07 | 2008-07-30 | Vertex Pharmaceuticals Incorporated | Benzimidazole derivatives as gyrase inhibitors |
GB0612428D0 (en) * | 2006-06-22 | 2006-08-02 | Prolysis Ltd | Antibacterial agents |
GB0724349D0 (en) * | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Antibacterial agents |
US8481544B2 (en) | 2006-06-22 | 2013-07-09 | Biota Europe Limited | Antibacterial compositions |
WO2009001915A1 (ja) * | 2007-06-28 | 2008-12-31 | Takeda Pharmaceutical Company Limited | 置換イミダゾール化合物およびその用途 |
WO2009027733A1 (en) * | 2007-08-24 | 2009-03-05 | Astrazeneca Ab | (2-pyridin-3-ylimidazo[1,2-b]pyridazin-6-yl) urea derivatives as antibacterial agents |
WO2009076200A2 (en) | 2007-12-07 | 2009-06-18 | Vertex Pharmaceuticals Incorporated | Solid forms of 1-ethyl-3-(5-(5-fluoropyridin-3-yl)-7-(pyrimidin-2-yl)-1h-benzo[d]imidazol-2-yl)urea |
GB0724342D0 (en) | 2007-12-13 | 2008-01-30 | Prolysis Ltd | Anitbacterial compositions |
CA2710194C (en) * | 2007-12-19 | 2014-04-22 | Amgen Inc. | Inhibitors of p13 kinase |
TW200940537A (en) * | 2008-02-26 | 2009-10-01 | Astrazeneca Ab | Heterocyclic urea derivatives and methods of use thereof |
ES2567283T3 (es) | 2008-06-03 | 2016-04-21 | Intermune, Inc. | Compuestos y métodos para tratar trastornos inflamatorios y fibróticos |
CA2725568A1 (en) | 2008-06-04 | 2009-12-10 | Astrazeneca Ab | Heterocyclic urea derivatives for the treatment of bacterial infections |
WO2009156966A1 (en) * | 2008-06-25 | 2009-12-30 | Ranbaxy Laboratories Limited | Benzothiazoles and aza-analogues thereof use as antibacterial agents |
CA2757368C (en) * | 2009-04-02 | 2019-03-12 | Merck Patent Gmbh | Piperidine and piperazine derivatives as autotaxin inhibitors |
US20120149710A1 (en) * | 2009-08-24 | 2012-06-14 | The Regents Of The University Of California | Sortase a inhibitors |
US20110120915A1 (en) * | 2009-11-24 | 2011-05-26 | Chevron U.S.A. Inc. | Hydrogenation of solid carbonaceous materials using mixed catalysts |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
US20150174137A1 (en) * | 2010-06-02 | 2015-06-25 | Alcon Research, Ltd. | Compositions for treating microbial infections |
CA2824403C (en) * | 2011-01-14 | 2019-09-24 | Vertex Pharmaceuticals Incorporated | Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea |
PT2663556E (pt) | 2011-01-14 | 2014-11-27 | Vertex Pharma | Processo de fabrico de inibidores de girase e topoisomerase iv |
SG191946A1 (en) * | 2011-01-14 | 2013-08-30 | Vertex Pharma | Pyrimidine gyrase and topoisomerase iv inhibitors |
MX351555B (es) * | 2011-01-14 | 2017-10-19 | Spero Trinem Inc | Formas solidas de inhibidor de girasa (r)-1-etil-3-[5-[2-(1-hidrox i-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzim idazol-2-il]urea. |
EP2721026B1 (en) | 2011-06-20 | 2016-03-02 | Vertex Pharmaceuticals Incorporated | Phosphate esters of gyrase and topoisomerase inhibitors |
US9018216B2 (en) | 2012-07-18 | 2015-04-28 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1H-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
WO2014014845A1 (en) * | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases |
AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
CA2915622C (en) | 2013-06-21 | 2020-08-18 | Zenith Epigenetics Corp. | Novel substituted bicyclic compounds as bromodomain inhibitors |
SG10201710705UA (en) | 2013-06-21 | 2018-02-27 | Zenith Epigenetics Ltd | Novel bicyclic bromodomain inhibitors |
JP6542212B2 (ja) | 2013-07-31 | 2019-07-10 | ゼニス・エピジェネティクス・リミテッドZenith Epigenetics Ltd. | ブロモドメイン阻害剤としての新規キナゾリノン |
CA2938459A1 (en) | 2014-02-03 | 2015-08-06 | Spero Gyrase, Inc. | Antibacterial compounds |
EP2913330A1 (en) * | 2014-02-27 | 2015-09-02 | Laboratoire Biodim | Condensed derivatives of imidazole useful as pharmaceuticals |
CN110452216B (zh) | 2014-04-02 | 2022-08-26 | 英特穆恩公司 | 抗纤维化吡啶酮类 |
EP3227281A4 (en) | 2014-12-01 | 2018-05-30 | Zenith Epigenetics Ltd. | Substituted pyridinones as bromodomain inhibitors |
CA2966449A1 (en) | 2014-12-11 | 2016-06-16 | Zenith Epigenetics Ltd. | Substituted heterocycles as bromodomain inhibitors |
US10231953B2 (en) | 2014-12-17 | 2019-03-19 | Zenith Epigenetics Ltd. | Inhibitors of bromodomains |
CN105884752B (zh) * | 2015-02-13 | 2018-08-31 | 山东轩竹医药科技有限公司 | 并环类回旋酶和拓扑异构酶iv抑制剂 |
EP3298005B1 (en) | 2015-05-21 | 2024-01-24 | The Regents of The University of California | Anti-cancer compounds |
CN106167486B (zh) * | 2015-05-22 | 2019-06-14 | 北京四环制药有限公司 | 单环类回旋酶和拓扑异构酶iv抑制剂 |
MX2017016788A (es) | 2015-07-02 | 2018-07-06 | Janssen Sciences Ireland Uc | Compuestos antibacterianos. |
WO2017216281A1 (en) | 2016-06-16 | 2017-12-21 | Janssen Sciences Ireland Uc | Heterocyclic compounds as antibacterials |
CN109843874B (zh) | 2016-06-24 | 2022-05-27 | 加利福尼亚大学董事会 | 作为parp1、parp2和/或微管蛋白的抑制剂可用于治疗癌症的酞嗪衍生物 |
US11224596B2 (en) | 2017-03-01 | 2022-01-18 | Janssen Sciences Ireland Unlimited Company | PZA and cytochrome bc1 inhibitor combination treatment |
US20210070747A1 (en) | 2017-03-24 | 2021-03-11 | Taisho Pharmaceutical Co., Ltd. | 2(1h)-quinolinone derivative |
CN110801455B (zh) * | 2019-11-12 | 2020-06-02 | 河北医科大学第二医院 | 用于治疗mrsa的药物组合物及其应用 |
US20230049619A1 (en) * | 2019-12-19 | 2023-02-16 | Universite De Strasbourg | Sigma-1 receptor ligands and uses thereof |
KR20230169573A (ko) * | 2022-06-09 | 2023-12-18 | 한국화학연구원 | 벤즈이미다졸 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암 또는 감염증의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2015676A1 (de) * | 1970-04-02 | 1971-10-21 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Neue Imine der 2-Formyl-chinoxalindi-N-oxidcarbon-säure-(3) und deren Salze, Verfahren zu ihrer Herstellung und ihre Verwendung als antimikrobielle Mittel |
US4174400A (en) | 1978-09-13 | 1979-11-13 | Merck & Co., Inc. | Anthelmintic benzimidazoles |
US4512998A (en) | 1980-10-20 | 1985-04-23 | Schering Corporation | Anthelmintic benzimidazole carbamates |
CA2028530A1 (en) | 1989-11-21 | 1991-05-22 | Christian Hubschwerlen | Substituted pyrimidobenzimidazole derivatives |
DE69220744T2 (de) * | 1991-09-27 | 1997-11-13 | Merrell Pharma Inc | 2-Substituierte Indan-2-Mercaptoacetylamid-Verbindungen mit Enkephalinase und ACE-Hemmwirkung |
DE19514313A1 (de) | 1994-08-03 | 1996-02-08 | Bayer Ag | Benzoxazolyl- und Benzothiazolyloxazolidinone |
HRP960159A2 (en) | 1995-04-21 | 1997-08-31 | Bayer Ag | Benzocyclopentane oxazolidinones containing heteroatoms |
US5643935A (en) | 1995-06-07 | 1997-07-01 | The University Of North Carolina At Chapel Hill | Method of combatting infectious diseases using dicationic bis-benzimidazoles |
TW538046B (en) | 1998-01-08 | 2003-06-21 | Hoechst Marion Roussel Inc | Aromatic amides having antiobiotic activities and the preparation processes, intermediates and pharmaceutical composition thereof |
AUPP873799A0 (en) | 1999-02-17 | 1999-03-11 | Fujisawa Pharmaceutical Co., Ltd. | Pyridine compounds |
GB9911594D0 (en) | 1999-05-19 | 1999-07-21 | Smithkline Beecham Plc | Novel compounds |
GB9912413D0 (en) | 1999-05-28 | 1999-07-28 | Pfizer Ltd | Compounds useful in therapy |
KR100944645B1 (ko) * | 2000-12-15 | 2010-03-04 | 버텍스 파마슈티칼스 인코포레이티드 | 자이라제 억제제 및 이를 포함하는 약제학적 조성물 |
WO2003105846A1 (en) | 2002-06-13 | 2003-12-24 | Vertex Pharmaceuticals Incorporated | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections |
AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
US7582641B2 (en) * | 2003-01-31 | 2009-09-01 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US7569591B2 (en) | 2003-01-31 | 2009-08-04 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US7618974B2 (en) * | 2003-01-31 | 2009-11-17 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
US8193352B2 (en) | 2003-01-31 | 2012-06-05 | Vertex Pharmaceuticals Incorporated | Gyrase inhibitors and uses thereof |
EP1948635A1 (en) | 2005-11-07 | 2008-07-30 | Vertex Pharmaceuticals Incorporated | Benzimidazole derivatives as gyrase inhibitors |
-
2004
- 2004-01-28 AR ARP040100257A patent/AR042956A1/es unknown
- 2004-01-29 ES ES04775744T patent/ES2327642T3/es not_active Expired - Lifetime
- 2004-01-29 EP EP04775744A patent/EP1592686B1/en not_active Expired - Lifetime
- 2004-01-29 WO PCT/US2004/002541 patent/WO2005012292A1/en active Application Filing
- 2004-01-29 RU RU2005127328/04A patent/RU2350612C2/ru not_active IP Right Cessation
- 2004-01-29 CA CA2513463A patent/CA2513463C/en not_active Expired - Fee Related
- 2004-01-29 AT AT04775744T patent/ATE435859T1/de active
- 2004-01-29 AU AU2004261545A patent/AU2004261545B2/en not_active Ceased
- 2004-01-29 DK DK04775744T patent/DK1592686T3/da active
- 2004-01-29 MX MXPA05008126A patent/MXPA05008126A/es active IP Right Grant
- 2004-01-29 ZA ZA200505773A patent/ZA200505773B/en unknown
- 2004-01-29 US US10/767,638 patent/US7495014B2/en not_active Expired - Fee Related
- 2004-01-29 MY MYPI20040267A patent/MY139124A/en unknown
- 2004-01-29 SI SI200431228T patent/SI1592686T1/sl unknown
- 2004-01-29 DE DE602004021904T patent/DE602004021904D1/de not_active Expired - Lifetime
- 2004-01-29 JP JP2006532271A patent/JP4691033B2/ja not_active Expired - Fee Related
- 2004-01-29 CN CNB2004800030868A patent/CN100393714C/zh not_active Expired - Fee Related
- 2004-01-29 PT PT04775744T patent/PT1592686E/pt unknown
- 2004-01-29 KR KR1020057014085A patent/KR20060056270A/ko active IP Right Grant
- 2004-01-29 NZ NZ541885A patent/NZ541885A/en unknown
- 2004-01-30 TW TW093102200A patent/TWI334416B/zh not_active IP Right Cessation
-
2005
- 2005-07-18 IL IL169720A patent/IL169720A/en not_active IP Right Cessation
- 2005-08-16 NO NO20053845A patent/NO20053845L/no not_active Application Discontinuation
-
2006
- 2006-07-14 HK HK06107863.3A patent/HK1087699A1/xx not_active IP Right Cessation
-
2008
- 2008-10-07 US US12/246,778 patent/US8188095B2/en not_active Expired - Fee Related
-
2009
- 2009-09-17 CY CY20091100962T patent/CY1109385T1/el unknown
-
2010
- 2010-12-06 JP JP2010272049A patent/JP2011046745A/ja not_active Withdrawn
-
2012
- 2012-04-24 US US13/454,510 patent/US20130023525A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05008126A (es) | Inhibidores de girasa y uso de los mismos. | |
ZA200701629B (en) | Gyrase inhibitors and uses thereof | |
PL374191A1 (en) | 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections | |
AP2003002824A0 (en) | Gyrase inhibitors and uses thereof | |
TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
UA94901C2 (ru) | Антибактериальные производные пиперидина | |
UA83875C2 (ru) | Производные хинолина для применения в качестве микобактериальных ингибиторов | |
UA88463C2 (ru) | Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции | |
TW200734344A (en) | Antibacterial agents | |
WO2006120563A3 (en) | Antibacterial agents | |
TW200630367A (en) | Substituted adenines and the uses thereof | |
TNSN07240A1 (en) | Compounds for flaviviridae treatment | |
NZ510369A (en) | Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection | |
DE602004012269D1 (de) | Quervernetzte glycopeptid-cephalosporin-antibiotika | |
EP1171428A4 (en) | FAB I INHIBITORS | |
MXPA05009712A (es) | Composiciones que comprenden acido hialuronico para la prevencion de infecciones urogenitales. | |
DE602004024393D1 (de) | Quervernetzte glycopeptid-cephalosporin-antibiotika | |
DE60208404D1 (de) | Kreuzverquerte glycopeptid-cephalosporin-antibiotika | |
SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
ATE335739T1 (de) | Cak inhibitoren und deren verwendungen | |
MXPA03005374A (es) | Carbazoles antitumorales. | |
DE60326710D1 (de) | Trizyklische antibakterielle makrolidderivate | |
WO2003068790A3 (en) | Macrolide antibacterial compounds | |
MY140242A (en) | BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS | |
CL2004000139A1 (es) | Compuestos derivados de bencimidazol, inhibidores de girasa; composicion farmaceutica; utiles en el tratamiento, prevencion o disminucion de infecciones bacterianas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |